VirginiaKaklamaniMD
Oncology • San Antonio, TXBreast Cancer, Hematologic Oncology
Professor of Medicine at University of Texas Health Science Center San Antonio
Dr. Kaklamani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7979 Wurzbach Rd FL Z5
San Antonio, TX 78229Phone+1 210-450-2872Fax+1 210-450-0407
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2000 - 2003
Newton-Wellesley HospitalResidency, Internal Medicine, 1997 - 2000
University of AthensClass of 1996
Certifications & Licensure
TX State Medical License 2014 - 2025
IL State Medical License 2000 - 2017- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Trastuzumab and Exemestane in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer Start of enrollment: 2002 Jul 01
- Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Start of enrollment: 2006 May 04
- Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
- Join now to see all
Publications & Presentations
PubMed
- 24 citationsEndocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor‐Positive Metastatic Breast CancerVirginia G. Kaklamani, William J. Gradishar
The Oncologist. 2017-05-01 - 69 citationsRace, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx TrialKathy S. Albain, Robert Gray, Della F. Makower, Amir Faghih, Daniel F. Hayes
Journal of the National Cancer Institute. 2021-04-06 - 1314 citationsAdjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerJoseph A. Sparano, Robert Gray, Della F. Makower, Kathleen I. Pritchard, Kathy S. Albain
The New England Journal of Medicine. 2018-06-03
Lectures
- Genomic stratification with BCI of ER+ early breast cancer patients with limited long-term risk of breast cancer death.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Other
- Axillary node metastases with occult primary breast cancerKaklamani V, Gradishar WJ
http://www.uptodate.com/contents/axillary-node-metastases-with-occult-primary-breast-cancer
UpToDate, Wolters Kluwer Health - 2012-08-07
Press Mentions
Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023May 26th, 2023- New Recommendations in Place for Breast Cancer ScreeningsMay 15th, 2023
- 3 Things You Didn’t Know to Ask Your Doctor —Until NowMay 4th, 2023
- Join now to see all
Professional Memberships
- Member
Other Languages
- Greek
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
